We are live on ! Find out more
DMK

David M. Knott Portfolio holdings

AUM $275M Turnover 23.21%
1-Year Est. Return 59.23%
This Fund
S&P 500
This Quarter Est. Return
-1.61%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$237M
AUM Growth
-$13.8M
Cap. Flow
-$6.52M
Cap. Flow %
-2.75%
Top 10 Hldgs %
59.31%
Holding
121
New
11
Increased
20
Reduced
8
Closed
10
Avg Time Held
2.4 years
Top 10 Avg Time Held
1.1 years
Top 20 Avg Time Held
1.3 years

Top Buys

Rank Stock Value
1
BRSL icon
Brightstar Lottery PLC
BRSL
+$6.7M
2
SRCL icon
Stericycle Inc
SRCL
+$2.29M
3
FTAI icon
FTAI Aviation
FTAI
+$1.97M
4
CLMT icon
Calumet Specialty Products
CLMT
+$1.49M
5
LGND icon
Ligand Pharmaceuticals
LGND
+$1.06M

Top Sells

Rank Stock Value
1
CFFN icon
Capitol Federal Financial
CFFN
+$8.97M
2
ORCL icon
Oracle
ORCL
+$8.06M
3
IRDM icon
Iridium Communications
IRDM
+$3M
4
CXW icon
CoreCivic
CXW
+$1.46M
5
ZGNX
Zogenix, Inc.
ZGNX
+$1.43M

Sector Composition

Rank Sector Weight
1 Healthcare 32.14%
2 Industrials 13.86%
3 Technology 10.97%
4 Consumer Discretionary 9.86%
5 Energy 8.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
HHH icon
26
Howard Hughes
HHH
$4.1B
$1.61M 0.68%
13,637
-13,532
-50% -$1.39M
2017 Q2
8 quarters
QTNT
27
DELISTED
Quotient Limited Ordinary Shares
QTNT
$1.59M 0.67%
4,250
– –
2017 Q4
6 quarters
STML
28
DELISTED
Stemline Therapeutics, Inc.
STML
$1.54M 0.65%
100,634
-57,161
-36% -$827K
2017 Q1
9 quarters
AB icon
29
AllianceBernstein
AB
$3.21B
$1.5M 0.63%
50,500
– –
2013 Q2
24 quarters
CELG
30
DELISTED
Celgene Corp
CELG
$1.47M 0.62%
15,847
+10,880
+219% +$1.03M
2019 Q1
1 quarter
CHRS icon
31
Coherus Oncology
CHRS
$153M
$1.38M 0.58%
62,387
+21,918
+54% +$381K
2017 Q2
8 quarters
CPRX icon
32
DELISTED
Catalyst Pharmaceutical
CPRX
$1.32M 0.56%
343,347
-167,500
-33% -$724K
2017 Q1
9 quarters
BMY icon
33
Bristol-Myers Squibb
BMY
$122B
$1.23M 0.52%
27,080
+21,652
+399% +$1.01M
2017 Q1
9 quarters
HZNP
34
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.2M 0.51%
50,046
+2,206
+5% +$56K
2018 Q2
4 quarters
AIMT
35
DELISTED
Aimmune Therapeutics
AIMT
$1.2M 0.5%
57,456
+2,400
+4% +$49.4K
2017 Q3
7 quarters
INDP icon
36
Indaptus Therapeutics
INDP
$350M
$1.13M 0.48%
116
-14
-11% -$177K
2018 Q3
3 quarters
APC icon
37
DELISTED
Anadarko Petroleum
APC
$1.13M 0.48%
15,960
– –
2013 Q2
24 quarters
ARNA
38
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.07M 0.45%
18,332
-18,344
-50% -$948K
2017 Q3
7 quarters
VZ icon
39
Verizon
VZ
$186B
$1.05M 0.44%
18,311
– –
2014 Q2
20 quarters
JNJ icon
40
Johnson & Johnson
JNJ
$616B
$1.01M 0.43%
7,280
– –
2013 Q2
24 quarters
RHP icon
41
Ryman Hospitality Properties
RHP
$8.69B
$1M 0.42%
12,400
– –
2013 Q2
24 quarters
FNM.PRT
42
DELISTED
FEDERAL NATL MTG ASS 08250
FNM.PRT
$996K 0.42%
+85,000
New +$996K
2019 Q2
0 quarters
DD icon
43
DuPont de Nemours
DD
$17.6B
$942K 0.4%
9,994
-4,871
-33% -$582K
2015 Q1
17 quarters
XRN.PRA icon
44
Chiron Real Estate Inc Series A Preferred Stock
XRN.PRA
$76.6M
$918K 0.39%
35,000
– –
2017 Q3
7 quarters
FOMX
45
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$883K 0.37%
371,046
+24,700
+7% +$73.8K
2018 Q4
2 quarters
CNQ icon
46
Canadian Natural Resources
CNQ
$111B
$873K 0.37%
66,059
– –
2017 Q2
8 quarters
MDLZ icon
47
Mondelez International
MDLZ
$81.6B
$857K 0.36%
15,900
– –
2013 Q2
24 quarters
ABBV icon
48
AbbVie
ABBV
$504B
$808K 0.34%
11,100
+6,100
+122% +$479K
2015 Q2
16 quarters
EPRT icon
49
Essential Properties Realty Trust
EPRT
$5.64B
$802K 0.34%
40,000
– –
2018 Q2
4 quarters
KMB icon
50
Kimberly-Clark
KMB
$35.1B
$800K 0.34%
6,000
– –
2017 Q3
7 quarters
1
2
3 4 5

Similar funds

FA
FMA Advisory Harrisburg, Pennsylvania $268M AUM 30.8% 1-Year Est. Return
KCP
KDI Capital Partners Raleigh, North Carolina $290M AUM 26.07% 1-Year Est. Return
HCIA
Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return
ISG
Investment Security Group Denver, Colorado $252M AUM 28.26% 1-Year Est. Return
TPCM
Three Peaks Capital Management Castle Rock, Colorado $301M AUM 43.39% 1-Year Est. Return
DCM
DeGreen Capital Management Scottsdale, Arizona $301M AUM 17.24% 1-Year Est. Return
MCL
MIK Capital LP New York $247M AUM 78.02% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

David M. Knott's Q2 2019 Portfolio in Review

As of Q2 2019, David M. Knott held 121 positions worth $237M, down 5.5% from $251M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

David M. Knott's Q2 2019 filing shows 11 new, 20 increased, 8 reduced and 10 closed positions. Its largest new stake was FEDERAL NATL MTG ASS 08250: 85,000 shares worth $996K. The largest sale was Capitol Federal Financial, an estimated $8.97M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Industrials and Technology.

  • David M. Knott's largest Q2 2019 buy was FEDERAL NATL MTG ASS 08250: 85,000 shares worth $996K.
  • David M. Knott added most to Brightstar Lottery PLC in Q2 2019, an estimated $6.7M increase.
  • David M. Knott's biggest Q2 2019 reduction was Capitol Federal Financial, cutting an estimated $8.97M.
  • David M. Knott fully exited Oracle in Q2 2019, selling an estimated $8.06M.
  • David M. Knott's ten largest holdings make up 59% of its $237M portfolio in Q2 2019.
  • David M. Knott opened 11 new positions and closed 10 in Q2 2019.
  • David M. Knott's portfolio value fell 5.5% quarter-over-quarter to $237M.

Based on David M. Knott's 13F filing for Q2 2019, filed 12 Aug 2019.